Fig. 2
From: Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
A novel CR risk signature for HCC clinical assessment. A The PPI network of 17 CR genes. B GO enrichment analysis of 17 CR genes. C The expressive heatmap of 17 CR genes. D Cross validation process in Lasso regression analysis, which is visualized through the alterations between partial-likelihood deviance (PLD) and Log(λ). E Changes in trajectory of variables. With the increase of λ, the coefficient of each variable is decreasing. When the coefficient of some variable attenuates to 0, it is indicative that this variable makes negligible contribution to the model and should be eliminated F The coefficients of 4 CR signature genes. G The relationships between CR risk levels and clinicopathological features of HCC